Syntara Limited

ASX:SNT Stock Report

Market Cap: AU$20.3m

Syntara Management

Management criteria checks 2/4

Syntara's CEO is Gary Phillips, appointed in Mar 2013, has a tenure of 11.08 years. total yearly compensation is A$753.60K, comprised of 61.3% salary and 38.7% bonuses, including company stock and options. directly owns 0.028% of the company’s shares, worth A$5.62K. The average tenure of the management team and the board of directors is 11.4 years and 6.5 years respectively.

Key information

Gary Phillips

Chief executive officer

AU$753.6k

Total compensation

CEO salary percentage61.3%
CEO tenure11.1yrs
CEO ownership0.03%
Management average tenure11.4yrs
Board average tenure6.5yrs

Recent management updates

Recent updates

Syntara Limited's (ASX:SNT) Low P/S No Reason For Excitement

Mar 14
Syntara Limited's (ASX:SNT) Low P/S No Reason For Excitement

We're Hopeful That Pharmaxis (ASX:PXS) Will Use Its Cash Wisely

Feb 28
We're Hopeful That Pharmaxis (ASX:PXS) Will Use Its Cash Wisely

Shareholders May Not Be So Generous With Pharmaxis Ltd's (ASX:PXS) CEO Compensation And Here's Why

Oct 27
Shareholders May Not Be So Generous With Pharmaxis Ltd's (ASX:PXS) CEO Compensation And Here's Why

Key Things To Understand About Pharmaxis' (ASX:PXS) CEO Pay Cheque

Mar 01
Key Things To Understand About Pharmaxis' (ASX:PXS) CEO Pay Cheque

We Think Pharmaxis (ASX:PXS) Can Afford To Drive Business Growth

Jan 04
We Think Pharmaxis (ASX:PXS) Can Afford To Drive Business Growth

CEO Compensation Analysis

How has Gary Phillips's remuneration changed compared to Syntara's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-AU$11m

Sep 30 2023n/an/a

-AU$18m

Jun 30 2023AU$754kAU$462k

-AU$11m

Mar 31 2023n/an/a

AU$2m

Dec 31 2022n/an/a

-AU$2m

Sep 30 2022n/an/a

AU$2m

Jun 30 2022AU$628kAU$451k

-AU$2m

Mar 31 2022n/an/a

-AU$16m

Dec 31 2021n/an/a

-AU$12m

Sep 30 2021n/an/a

-AU$1m

Jun 30 2021AU$683kAU$444k

-AU$3m

Mar 31 2021n/an/a

AU$5m

Dec 31 2020n/an/a

-AU$4m

Sep 30 2020n/an/a

-AU$13m

Jun 30 2020AU$559kAU$440k

-AU$14m

Mar 31 2020n/an/a

-AU$21m

Dec 31 2019n/an/a

-AU$18m

Sep 30 2019n/an/a

-AU$18m

Jun 30 2019AU$613kAU$433k

-AU$20m

Mar 31 2019n/an/a

-AU$27m

Dec 31 2018n/an/a

-AU$12m

Sep 30 2018n/an/a

-AU$22m

Jun 30 2018AU$776kAU$424k

AU$6m

Mar 31 2018n/an/a

AU$10m

Dec 31 2017n/an/a

-AU$1m

Sep 30 2017n/an/a

AU$7m

Jun 30 2017AU$799kAU$423k

-AU$18m

Compensation vs Market: Gary's total compensation ($USD492.32K) is above average for companies of similar size in the Australian market ($USD292.80K).

Compensation vs Earnings: Gary's compensation has increased whilst the company is unprofitable.

CEO

Gary Phillips (62 yo)

11.1yrs

Tenure

AU$753,599

Compensation

Mr. Gary Jonathan Phillips, BPharm, MBA, serves as Independent Non-Executive Director at Arovella Therapeutics Limited since July 1, 2022. He has been Chief Executive Officer and Managing Director of Synta...

Leadership Team

NamePositionTenureCompensationOwnership
Gary Phillips
CEO, MD & Director11.1yrsAU$753.60k0.028%
A$ 5.6k
David McGarvey
CFO & Company Secretary21.3yrsAU$555.57k0.087%
A$ 17.7k
Wolfgang Jarolimek
Head of Drug Discovery11.7yrsAU$541.14k0.14%
A$ 29.3k
Kristen Morgan
Head of Medical & Regulatory Affairs - Alliance Managementno dataAU$323.75k0.027%
A$ 5.6k
Jana Baskar
Chief Medical Officer1.8yrsAU$429.39k0.034%
A$ 6.8k
Cameron Billingsley
General Counselno datano datano data

11.4yrs

Average Tenure

59yo

Average Age

Experienced Management: SNT's management team is seasoned and experienced (11.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Gary Phillips
CEO, MD & Director11.1yrsAU$753.60k0.028%
A$ 5.6k
Neil Graham
Non-Executive Director3.9yrsAU$85.23kno data
Malcolm McComas
Independent Director20.8yrsAU$115.23k0.21%
A$ 42.1k
Alan Robertson
Member of Scientific Advisory Boardno dataAU$711.06kno data
Simon Green
Independent Non-Executive Director1.3yrsAU$37.96k0.076%
A$ 15.5k
Darren Kelly
Member of Scientific Advisory Board6.5yrsno datano data
Kathleen M. Metters
Member of Scientific Advisory Board & Independent Chair6.8yrsAU$85.23k0.0017%
A$ 341.0
Andrew Boyle
Member of Scientific Advisory Boardno datano datano data
Jacob George
Member of Scientific Advisory Boardno datano datano data
Carol Pollock
Member of Scientific Advisory Boardno datano datano data
Waradana Malitha De Silva
Non-Executive Director1.3yrsAU$32.40k0.027%
A$ 5.4k

6.5yrs

Average Tenure

66yo

Average Age

Experienced Board: SNT's board of directors are considered experienced (6.5 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.